Transmedics.
Company
- Reports this week
- 3
- Active events
- 1
- Connections
- 40
What's happening
Active this week
Gone quiet
No new reports in 90+ days-
SoFi, Robinhood, and Transmedics are mentioned as financial services companies and investment opportunities.Some support1 report1 development inside
-
Hernandez is named as the Chief Financial Officer (CFO) of TransMedics.Some support1 report
-
Transmedics is headquartered in Andover, MA.Some support4 reports
-
An investigation into corporate governance issues has begun concerning Transmedics at One World Trade Center.Some support1 report
-
Transmedics, a US-based company, is investing in Germany and working to create an organ transplant network across Europe.Some support1 report
-
Nvidia and Transmedics are being discussed in the context of investment signals.Some support2 reports
-
The FDA granted conditional IDE approval for TransMedics utilizing the OCS Heart System.Some support3 reports
-
Transmedics trades on the Nasdaq stock exchange and files disclosures with the SEC.Well supported5 reports
-
OrganOx Metra removed its air transport warning from its label.Speculative1 report
-
A sale decision was prompted by Transmedics' strong Q1 report, according to Headwaters Capital Management.Some support1 report
-
Veracyte and Transmedics operate within the same molecular diagnostic industry.Some support1 report1 development inside
-
OCS technology is cited as a key factor driving the growth of Transmedics.Some support4 reports1 development inside
-
OCS technology was cited for keeping donated organs healthy and providing better outcomes for transplant recipients.Some support5 reports
-
Transmedics is noted as being involved in the broader trend of AI changing the healthcare sector.Some support1 report
-
Transmedics entered international markets via a facility in Italy.Some support2 reports
-
FDA approval is identified as a key regulatory catalyst for Transmedics.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Transmedics this week
News at the entities that move Transmedics most-
FDA StructuralFDA issued a warning letter to NeoGen regarding a product quality defect on October 7, 2026.Moves Transmedics
-
Hernandez StructuralHernandez focuses on infrastructure in Webb County.Moves Transmedics
-
Italy StructuralMacron launched a new initiative within the EPC framework, with Meloni leading Italy's participation, focusing on EU Drug Strategy.Moves Transmedics
-
Nasdaq StructuralGilat Satellite Networks Ltd. shares traded on Nasdaq, concurrent with William Blair downgrading the stock and Comtech's acquisition remaining on track.Moves Transmedics
-
Needham & Company Mentioned togetherNeedham & Company provided research reports on Geron Corporation, coinciding with a filing with the SEC confirming institutional investment activity.Moves Transmedics
-
SEC StructuralMSCI index rules may affect Bitcoin companies, while warnings caused stock market crashes in Turkey and Indonesia.Moves Transmedics
Connections
The 18 strongest of 40, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
OCS Structural
OCS technology is the core product driving Transmedics' growth and market operations in organ transplant procedures.
-
Nasdaq Structural
Transmedics is listed on the Nasdaq stock exchange platform.
-
Italy Structural
Transmedics has established a manufacturing presence in Italy and secured its first European tender there.
-
Fernando Araujo Structural
Fernando Araujo serves as the Chief Financial Officer of Transmedics.
-
FDA Structural
Transmedics' products depend on FDA regulatory approvals and oversight for market operation.
-
London Health Sciences Centre Structural
LHS Centre provides the necessary Organ Care System for Transmedics' transplant operations.
-
Hernandez Structural
Hernandez holds the position of Chief Financial Officer at Transmedics.
-
Brian Johnston Transactional
Brian Johnston holds the role of Investor Contact for Transmedics.
Show all 18 connections
-
SEC Structural
Transmedics operates under the regulatory oversight of the SEC, requiring formal financial disclosures.
-
Europe Shared context
Transmedics is conducting market expansion and establishing transplant networks within the European geographical context.
-
SoFi Mentioned together
Both SoFi and Transmedics are mentioned in the same context as investment opportunities.
-
Nvidia Mentioned together
Nvidia and Transmedics are co-mentioned as examples of investment opportunities and growth signals.
-
Needham & Company Mentioned together
Needham & Company provides analyst ratings and target price cuts for Transmedics.
-
Andover Shared context
Transmedics is headquartered in Andover, Massachusetts.
-
Massachusetts Shared context
Transmedics is headquartered in the state of Massachusetts.
-
Boston Shared context
TransMedics is scheduled to participate in a conference held in Boston.
-
Andover Shared context
Transmedics is headquartered in Andover, Massachusetts.
-
One World Trade Center Shared context
The entities are linked in the context of a corporate governance investigation.
History
Events by the month they beganNovember 2026
1 eventAugust 2026
1 eventJuly 2026
4 events- SoFi, Robinhood, and Transmedics are mentioned as financial services companies and investment opportunities.
- An investigation into corporate governance issues has begun concerning Transmedics at One World Trade Center.
- Transmedics, a US-based company, is investing in Germany and working to create an organ transplant network across Europe.
- Nvidia and Transmedics are being discussed in the context of investment signals.
Show 1 earlier month
June 2026
11 events- Transmedics is headquartered in Andover, MA.
- The FDA granted conditional IDE approval for TransMedics utilizing the OCS Heart System.
- Transmedics trades on the Nasdaq stock exchange and files disclosures with the SEC.
- OrganOx Metra removed its air transport warning from its label.
- A sale decision was prompted by Transmedics' strong Q1 report, according to Headwaters Capital Management.
- Veracyte and Transmedics operate within the same molecular diagnostic industry.
- OCS technology is cited as a key factor driving the growth of Transmedics.
- OCS technology was cited for keeping donated organs healthy and providing better outcomes for transplant recipients.
- Transmedics is noted as being involved in the broader trend of AI changing the healthcare sector.
- Transmedics entered international markets via a facility in Italy.
- FDA approval is identified as a key regulatory catalyst for Transmedics.